https://www.ajmc.com/journals/supplement/2005/2005-07-vol11-n4suppl/jul05-2093ps099-s100
PARTICIPATING FACULTY


This supplement to The American Journal of Managed Care includes information on overactive bladder, including costs, treatments, and impact on patients'quality of life.

Faculty
Tamara Bavendam, MD
Director, Team Leader
US Medical, Detrol
Pfizer Inc
New York, New York

Steven Blume, MS
Senior Project Manager
The MEDTAP Institute at UBC
Bethesda, Maryland

Morgan S. Bron, PharmD, MS
Manager, Depression and Anxiety
Disease Management Team
US Outcomes Research
Pfizer Inc
New York, New York

Theodore Darkow, PharmD
Researcher
i3 Magnifi, an Ingenix Company
Health Economics and Outcomes Group
Eden Prairie, Minnesota

Jennifer R. Frytak, PhD
Senior Researcher
i3 Magnifi, an Ingenix Company
Health Economics and Outcomes Group
Eden Prairie, Minnesota

Alan D. Garely, MD
Chief, Gynecology, Department of Obstetrics & Gynecology
Director, Division of Urogynecology and Pelvic
Reconstructive Surgery
Winthrop University Hospital
Mineola, New York

Prafulla Girase, MS
Senior Programmer/Analyst
Pfizer Inc
New York, New York

Anna Gu, MA
Graduate Research Assistant, PhD Student
University of Maryland
School of Pharmacy
Pharmaceutical Health Services
Research Department
Baltimore, Maryland

Zhanna Jumadilova, MD, MBA
Senior Manager
US Outcomes Research
Pfizer Inc
New York, New York

Yu Ko, MS
Doctoral Student and Graduate Associate
Department of Pharmaceutical Sciences
College of Pharmacy
University of Arizona
Tucson, Arizona
Swu-Jane Lin, PhD
Assistant Professor
Department of Pharmacy Administration
College of Pharmacy
University of Illinois at Chicago
Chicago, Illinois

C. Daniel Mullins, PhD
Associate Director
Center for Pharmacoeconomic Research
University of Maryland School of Pharmacy
Baltimore, Maryland

Siva Narayanan, MS, MHS
Director
Outcomes Research, Pharmacy Consulting Group
Beverly Enterprises, Inc
Fort Smith, Arkansas

Nicole M. Nitz, PhD
Researcher
i3 Magnifi, an Ingenix Company
Health Economics and Outcomes Group
Eden Prairie, Minnesota

Daniel A. Ollendorf, MPH
Vice President
Analytic & Consulting Services
PharMetrics, Inc
Watertown, Massachusetts

Barbara Paul, MD
Senior Vice President
Chief Medical Officer
Beverly Enterprises, Inc
Fort Smith, Arkansas

Eleanor M. Perfetto, PhD
Managing Consultant
Epidemiology & Biostatistics
The Weinberg Group Inc
Washington, DC

Richard G. Roberts, MD, JD
Professor
Department ofFamily Medicine
University of Wisconsin Medical School
Madison, Wisconsin

J. Warren Salmon, PhD
Professor of Pharmacy Administration
College of Pharmacy
Professor of Health Policy and Management
School of Public Health
University of Illinois at Chicago
Chicago, Illinois

Fadia T. Shaya, PhD, MPH
Assistant Professor
Associate Director
Center on Drugs and Public Policy
University of Maryland School of Pharmacy
Baltimore, Maryland

Leslee L. Subak, MD
Obstetrician/Gynecologist
Gynecology and Continence Program
University of California
UCSF Women's Health-Mount Zion Campus
San Francisco, California

Prasun Subedi, MS
Pharmaceutical Health Services Research
University of Maryland
School of Pharmacy
Baltimore, Maryland

Sujata Varadharajan, MS
Research Associate
Pfizer Inc
New York, New York

Teresa Zyczynski, PharmD, MBA, MPH
Senior Director
US Outcomes Research
Pfizer Inc
New York, New York

Faculty Disclosure

It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.

These participants report relationships with the following pharmaceutical companies:

These participants report no relationships with pharmaceutical companies:

These participants are employees of Pfizer:

These participants are employees of i3 Magnifi or MEDTAP Institute at UBC, which perform work funded by a variety of pharmaceutical companies, including Pfizer:

Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.

This program is being supported by an educational grant from Pfizer.

The contents of this supplement may include information regarding the use of products that may be inconsistent outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

Print | AJMC Printing...